Effect of mesenchymal stem cells and fibroblast cells on chronic wound healing

Effect of skin substitutes prepared from co-cultured mesenchymal stem cells and fibroblast cells cultured on amniotic membrane in chronic wound healing

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20090128001605N17

Enrollment

Registered

2018-10-09

Start date

2018-09-23

Completion date

Unknown

Last updated

2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic wound. Chronic ulcer of skin, not elsewhere classified

Interventions

Intervention 1: Intervention group 1: The wound of patients is covered with amniotic membrane . Intervention 2: Intervention group2: Patients whose wound is covered with the amniotic membrane mesenchy

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with chronic wound less than 1% of body surface due to vascular (arterial, venous and lymphatic), diabetic, radiotherapy, bed sore and ...

Exclusion criteria

Exclusion criteria: Pregnant Women Any patients that is treated with medications that makes wound healing problematic, malignancy, or osteomyelitis in the wound

Design outcomes

Primary

Measure	Time frame
Wound surface. Timepoint: every 3 days until 9 days after intervention. Method of measurement: Metric Software.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Akbar Mohammadi

Shiraz University of Medical Sciences

mohamadiaa@sums.ac.ir+98 71 3821 9638

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026